Naftidrofuryl mitigates LPS-induced pulmonary injury through macrophage polarization and NLRP3/TLR4 regulation, an in vitro and in vivo perspective
NAF may serve as a potential pulmonary protective agent against ALI by restoring inflammatory homeostasis and modulating various inflammatory pathways.
Authors
- Hebatallah M. Saad (ORCID: https://orcid.org/0000-0001-9555-7300)
- Dalia Zaafar (ORCID: https://orcid.org/0000-0002-7201-3658)
- Ehab A. M. El‐Shoura (ORCID: https://orcid.org/0000-0003-2448-7549)
- Abdulrahman S. Bahashwan (ORCID: https://orcid.org/0000-0001-9730-215X)
Institutions
- Cairo University (EG)
- Al-Azhar University (EG)
- Taibah University (SA)
- Egypt Nanotechnology Center (EG)
- Al-Azhar University (ID)
- Al Azhar University (QA)
- Assiut University (EG)
Publication Details
- Journal
- Immunopharmacology and Immunotoxicology
- Published
- 2025-11-02
- DOI
- https://doi.org/10.1080/08923973.2025.2586129
- Primary Topic
- Genomics, phytochemicals, and oxidative stress
- Type
- article
- Field-Weighted Citation Impact
- 0.00